Daniel R. Marshak, Ph.D.

Dr. Marshak serves as Chairman of InVivo’s Compensation Committee and a member of the Audit Committee. He currently serves as part-time Chief Technology Officer to Phase Scientific International Ltd., a medical device and clinical diagnostics company. Prior to that, he recently held the positions as Senior Vice President and Chief Scientific Officer for PerkinElmer, Inc. In those roles, Dr. Marshak led PerkinElmer’s research and development functions while helping to drive growth across the organization. Prior to joining PerkinElmer, Dr. Marshak was Vice President and Chief Technology Officer, Biotechnology, for Cambrex Corporation. He previously served as Senior Vice President and Chief Scientific Officer for Osiris Therapeutics, Inc., where he led stem cell research and development from inception to late-stage clinical trials. Before Osiris, he was a Senior Staff Investigator at Cold Spring Harbor Laboratory. Dr. Marshak has received numerous awards for scientific and academic achievements and is named as inventor on six issued U.S. patents. He currently serves on the International Society for Stem Cell Research Global Advisory Council and has also served on their Board of Directors. Dr. Marshak is the author of more than 100 scientific publications, including one textbook, and has been the editor of five monographs. He recently held an appointment as Adjunct Associate Professor at the Johns Hopkins University School of Medicine and previously taught graduate biochemistry as an Assistant Professor at the State University of New York. Dr. Marshak holds his B.A. in biochemistry and molecular biology from Harvard University, and he holds a doctorate in biochemistry and cell biology from The Rockefeller University.